Ignite Creation Date:
2025-12-25 @ 3:40 AM
Ignite Modification Date:
2026-03-05 @ 8:51 AM
Study NCT ID:
NCT00112502
Status:
COMPLETED
Last Update Posted:
2021-10-18
First Post:
2005-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-02
First Submit QC Date:
None
Study First Post Date:
2005-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-08-11
Results First Submit QC Date:
None
Results First Post Date:
2021-10-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-21
Last Update Post Date:
2021-10-18
Last Update Post Date Type:
ACTUAL